Skip to main content

Table 4 Estimation of effective half-life, activity at infusion time, and corresponding local absorbed dose for volumes V1, V2, and V3

From: Tissue dose estimation after extravasation of 177Lu-DOTATATE

  Effective half-life Teff (h) A0 (MBq) Estimated dose (Gy)
V1 2.39 ± 0.002 7471 ± 26 2.26 ± 0.07
V2 2.257 ± 0.002 5715 ± 20 4.07 ± 0.13
V3 2.256 ± 0.002 3592 ± 13 6.77 ± 0.22